Impact of a Previous CS on the Ongoing Pregnancy Rate in Single Euploid Frozen Embryo Transfer (ET)

Recruiting Observational Study
Infertility Implantation
No Placebo Group Every participant receives an active treatment — no one gets a placebo. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 – 42
Sex
Female
Study type
Observational
Participants needed
1,050 (estimated)
Sponsor
ART Fertility Clinics LLC · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

As embryo ploidy is a crucial factor not only for implantation but also for maintenance of a pregnancy, the aim of this study is to evaluate the impact of the CS / isthmocele on the ongoing pregnancy rates and the implantation site in single euploid frozen embryo transfer, independent of the endometrial preparation approach.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: \- All participants undergoing a single euploid FET, independent of the endometrial preparation approach Exclusion Criteria: * Intracavitary fluid during preparation for FET * Known anomaly of the uterus or the adnexae (e.g.: fibroids, polyps, hydrosalpinx, endometriosis, aden…
Contacts

Barbara Lawrenz, PhD

+971 2 652 8000

barbara.lawrenz@artfertilityclinics.com

CONTACT

Jonalyn Edades

+971 2 652 8000

jonalyn.edades@artfertilityclinics.com

CONTACT